AsoGen Therapeutics IVS
Credit rating
Company information
About AsoGen Therapeutics IVS
AsoGen Therapeutics IVS (CVR number: 40357092) is a company from ODENSE. The company recorded a gross profit of -7 kDKK in 2020. The operating profit was -18.1 kDKK, while net earnings were -39.3 kDKK. The profitability of the company measured by Return on Assets (ROA) was -6.3 %, which can be considered poor and Return on Equity (ROE) was -15.6 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -19 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. AsoGen Therapeutics IVS's liquidity measured by quick ratio was 1.3 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | |
---|---|---|
Volume | ||
Net sales | ||
Gross profit | -5.00 | -7.01 |
EBIT | -5.00 | -18.09 |
Net earnings | -16.64 | -39.30 |
Shareholders equity total | -16.44 | -55.74 |
Balance sheet total (assets) | 264.51 | 238.39 |
Net debt | 119.83 | 250.32 |
Profitability | ||
EBIT-% | ||
ROA | -1.8 % | -6.3 % |
ROE | -6.3 % | -15.6 % |
ROI | -1.9 % | -6.8 % |
Economic value added (EVA) | -5.00 | -10.17 |
Solvency | ||
Equity ratio | -5.9 % | -19.0 % |
Gearing | -1587.0 % | -487.3 % |
Relative net indebtedness % | ||
Liquidity | ||
Quick ratio | 8.3 | 1.3 |
Current ratio | 8.3 | 1.3 |
Cash and cash equivalents | 141.13 | 21.31 |
Capital use efficiency | ||
Trade debtors turnover (days) | ||
Net working capital % | ||
Credit risk | ||
Credit rating | B | B |
Variable visualization
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.